Non-invasive method to objectively determine the dynamics of the tear film and diagnose dry- eye disease (DED)

Patent number:

PCT_ES2018_070336

Cataluña.svg
No items found.

A new system for the assessment of the tear film quality and the diagnosis of dry-eye has been developed. Based on a non-invasive recording of images of the light reflected on the tear-film of the eye, posterior image processing allows the objective assessment of dry-eye. It’s a simple and cost-effective system easy to use in clinics. Dry-eye disease is prevalent among 14.5% of population worldwide (17.9% in women and 10.% in men), which is expected to increase in developed countries with continuous aging. Dry eye occurs when the tear film which protect the ocular surface is injured and its normal function is disturbed. This multifactorial disease of the tear film and ocular surface results in symptoms of discomfort, visual disturbance and instability with potential damage to the ocular surface. There is an increasing difficulty in diagnosing the severity of the condition, as there are not too many modalities to diagnose it, the most common tests used in clinical practice for the diagnosis of dry-eye are either subjective, as questionnaires or invasive as the assessment of stability of tear film or its break-up time. In recent years great efforts have been made to develop objective and non-invasive methods for dry-eye analysis based on new technologies such as corneal topography, These methods are based in expensive instrumentation with the consequent impact in the cost of the tests for the patients.

Countries:
Spain
Regions:
Catalonia
Centers:
UNIVERSITAT POLITECNICA DE CATALUNYA
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

Non-invasive measurement Objective assessment of dry eye disease Low-cost device and fast processing time Easy and friendly use in Ophthalmology Clinics Can be incorporated to an existing device as a module or implemented as a stand-alone instrument

Comments

Other related patents

Health

POLYCERASOIDOL AND POLYCERASOIDIN DERIVATIVES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES, TYPE 2 DIABETES MELLITUS, HYPERCHOLESTEROLEMIA, DYSLIPIDEMIAS AND ATHEROSCLEROSIS.

Countries
Spain
Know more
Health

Use of aloe oral for hair improvement

Countries
Spain
Know more
Health

ATR inhibitors

Countries
Spain
Know more
Get back to patents directory